Preveta

Preveta

Series

Unknown

AI-powered care navigation and clinical analytics for Oncology, Urology, and GI

AI-powered care navigation and clinical analytics for Oncology, Urology, and GI

FOUNDED

FOUNDED

2018

2018

TOTAL FUNDING

TOTAL FUNDING

TOTAL FUNDING

$8.3M

$8.3M

LATEST STAGE

LATEST STAGE

Series A

Series A

2023

2023

HEADCOUNT

HEADCOUNT

11-50

11-50

PRODUCT OVERVIEW

Preveta's AI-powered platform turns complex EMR data into structured clinical workflows built on specialty-specific clinical pathways—such as for oncology, urology, and GI. It guides patient navigators through what actions to take, surfaces gaps in care, highlights candidates for second- and third-line therapies or clinical trials, and continuously cleanses and enriches data. The goal is improved early detection, better outcomes, and streamlined chronic care management operations.

Show more

NURSE FOUNDER

COMPANY INFO

Status

Active

HQ

Redondo Beach, CA

Category

Clinical Software

Profile claimed?

Unclaimed

INVESTORS

Lead

MaC Venture Capital

Bullpen Capital, Sovereign's Capital, TSVC

ACCELERATORS

PRODUCT OVERVIEW

Preveta's AI-powered platform turns complex EMR data into structured clinical workflows built on specialty-specific clinical pathways—such as for oncology, urology, and GI. It guides patient navigators through what actions to take, surfaces gaps in care, highlights candidates for second- and third-line therapies or clinical trials, and continuously cleanses and enriches data. The goal is improved early detection, better outcomes, and streamlined chronic care management operations.

FUNDING TIMELINE

Funding timeline here

Funding timeline here

IN THE NEWS

NURSE FOUNDER

COMPANY INFO

Status

Active

HQ

Redondo Beach, CA

Category

Clinical Software

Profile claimed?

Unclaimed

INVESTORS

Lead

MaC Venture Capital

Bullpen Capital, Sovereign's Capital, TSVC

ACCELERATORS

Techstars LA

2020